Are you Dr. Farokhzad?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 82 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Dept Of Anesthesiology Perioperative And Pain Medicine
Boston, MA 02115Phone+1 617-732-8210
Summary
- Dr. Omid Farokhzad, MD is an anesthesiologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is affiliated with Brigham and Women's Hospital and is an Associate Professor of Anaesthesia at Brigham and Women's Hospital.
Education & Training
- Brigham and Women's HospitalFellowship, Pain Medicine, 2006 - 2007
- Brigham and Women's HospitalResidency, Anesthesiology, 2001 - 2004
- Beth Israel Deaconess Medical CenterResidency, Surgery, 1999 - 2001
- Boston University School of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2006 - 2026
- MA State Medical License 2002 - 2020
Publications & Presentations
PubMed
- 1105 citationsTargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoOmid C. Farokhzad, Jianjun Cheng, Benjamin A. Teply, Ines Sherifi, Sangyong Jon
Proceedings of the National Academy of Sciences of the United States of America. 2006-04-18 - 2179 citationsFactors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesFrank Alexis, Eric M. Pridgen, Linda K. Molnar, Omid C. Farokhzad
Molecular Pharmaceutics. 2008-08-04 - 413 citationsAn Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform†Vaishali Bagalkot, Omid C. Farokhzad, Robert Langer, Sangyong Jon
Angewandte Chemie. 2006-12-11
Press Mentions
- 40th Anniversary Recollections & PredictionsOctober 4th, 2021
- JP Morgan Healthcare Conference 2021, Day One: Roche, Seer, 10x, Guardant, Hologic, Thermo FisherJanuary 12th, 2021
- UPDATED: Four Biotechs Hit Wall Street with Upsized IPOs, Each Raising More Than $20M over Their GoalsDecember 4th, 2020
- Join now to see all
Grant Support
- Development Of Fcrn-Targeted Nanoparticles For Efficient Oral Delivery Of InsulinNational Institute Of Biomedical Imaging And Bioengineering2012
- Development Of Disease-Specific Drug Delivery VehiclesNational Institute Of Biomedical Imaging And Bioengineering2005–2009